MAY 10, 2018 01:49 PM PDT

New Biomarker for Lung Cancer Diagnosis

WRITTEN BY: Kara Marker

Lung cancer is the most common cause of death from cancer for both genders and for people all over the globe. This is largely due to the lack of diagnostic markers that indicate early stages of cancer. But now, scientists from a new Japan study introduce a biomarker that could drastically change cancer diagnostics and treatment: CKAP4.

Histopathology of small cell lung carcinoma. Credit: Yale Rosen

There are several existing biomarkers that scientists use to diagnose lung cancer:

  • Carcinoma embryonic antigen (CEA)
  • Sialyl Lewis X antigen (SLX)
  • Squamous cell carcinoma (SCC) antigen
  • Cytokeratin fragment (CYFRA) 21-1

But none of them are sensitive enough to detect lung cancer in its early stages, and this is a huge problem for diagnosis, prognosis, and treatment of patients affected.

In the new study, researchers used several lab techniques to test a monoclonal antibody called KU-Lu-1. A monoclonal antibody is a lab-derived protein that binds to other proteins in the body. In this case, KU-Lu-1 only targeted tumor cells from lung cancer tissues, not normal lung tissues. Researchers first tested KU-Lu-1 in blood samples from 271 different lung cancer patients and 100 healthy individuals.

After confirming that KU-Lu-1 only targeted cancerous tissue, researchers observed that KU-Lu-1 targets lung cancer cells by recognizing cytoskeleton-associated protein 4 (CKAP4).

"The results of our study provide evidence that the CKAP4 protein may be a novel early sero-diagnostic marker for lung cancer,” explained co-investigator Ryo Nagashio, PhD.

"The use of CKAP4 as a biomarker could change current practices regarding the treatment of lung cancer patients, and the diagnostic accuracies may be markedly improved by the combination of CKAP4 and conventional markers," explained study leader Yuichi Sato, PhD.

CKAP4 is a receptor of another protein called Dickkopf1 (DKK1). When both of these proteins are expressed, prognosis worsens and the chance of relapse-free survival for lung cancer patients minimizes.

"The identification of patients at an early stage of cancer when it can be treated surgically is extremely important to improve prognosis," Sato concluded. "We need better biomarkers for early diagnosis."

The present study was published in the American Journal of Pathology.

Sources: Elsevier, National Cancer Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
NOV 17, 2019
Genetics & Genomics
NOV 17, 2019
Increasing Evidence Shows Narcolepsy is an Autoimmune Illness
Narcolepsy is a chronic sleep disorder impacting as many as 200,000 people in the US, and is thought to often go undiagnosed....
NOV 17, 2019
Health & Medicine
NOV 17, 2019
Balanced Gut Bacteria May Relieve Anxiety Symptoms
The Anxiety and Depression Association of America estimates that 18% of adults in the United States suffer from an anxiety disorder. According to the World...
NOV 17, 2019
NOV 17, 2019
The Right Cocktail of Gut Microbes may Prevent or Reverse Food Allergies
Food allergies are a growing public health concern. New work may help pave the way for a therapeutic that reduces or stops allergies....
NOV 17, 2019
NOV 17, 2019
Making Opioids Safer
The opioid crisis results in 130 American deaths every day, and both prescribed and synthetic opioids are at the core of the epidemic.  Any other drug...
NOV 17, 2019
NOV 17, 2019
Treating Celiac Disease May Be Possible
Delivering gluten to the body in a friendly, harmless package may be the way for people with celiac disease to finally have a sandwich again. A new clinica...
NOV 17, 2019
NOV 17, 2019
Immunity to HPV Can Prevent Skin Cancer
Scientists discovered a surprise benefit of low-risk human papillomaviruses (HPV), a typical resident of human skin. New research shows that these harmless...
Loading Comments...